Role Of Trastuzumab in HER2+ Breast Cancer. Importance of Combined Therapy

publicité

publicité

Documents connexes

N E W S Correction

N E W S Correction

patritumab selected for I-SPY 2 TRIAL in breast cancer.docx

patritumab selected for I-SPY 2 TRIAL in breast cancer.docx

A STUDY OF PLUS CAPECITABINE VERSUS LAPATINIB PLUS CAPECITABINE IN PATIENTS WITH

A STUDY OF PLUS CAPECITABINE VERSUS LAPATINIB PLUS CAPECITABINE IN PATIENTS WITH

ETUDES (CLINIQUE DU SEIN)

ETUDES (CLINIQUE DU SEIN)

NEWS IN BRIEF Neratinib Graduates to I-SPY 3

NEWS IN BRIEF Neratinib Graduates to I-SPY 3

Open access

Development of aptamer-based radiopharmaceuticals for targeted cancer imaging and therapy

Development of aptamer-based radiopharmaceuticals for targeted cancer imaging and therapy

I-SPY 2 Shows Efficacy of T-DM1-Pertuzumab.docx

I-SPY 2 Shows Efficacy of T-DM1-Pertuzumab.docx

A novel inhibitor of fatty acid synthase shows

A novel inhibitor of fatty acid synthase shows

HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction

HER2 expression and relevant clinicopathological features in gastric and gastroesophageal junction

Resistance to therapy in estrogen receptor

Resistance to therapy in estrogen receptor

TFG estherjimenezgimenez

TFG estherjimenezgimenez